Table of Contents
1 Industry Outlook
1.1 Industry Overview
1.2 Patient Demography
1.3 Healthcare Spending in the US
1.4 Total Addressable Market
1.4.1 Cardiac Rhythm Management (CRM)
1.5 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition - Infoholic Research
3.2 Segmented Addressable Market
3.3 Industry Trends
3.4 Related Markets
3.4.1 Cardiovascular Drugs
3.4.1.1 Trends of cardiovascular drugs market
3.4.2 Aortic Aneurysm
3.4.2.1 Trends of Aortic Aneurysm Market
3.4.3 Coronary Stents Market
3.4.3.1 Trends of Coronary Stents Market
3.4.4 Cardiovascular Diagnostics
4 Market Outlook
4.1 Reimbursement Scenario
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
4.4 PEST Analysis
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing prevalence of cardiovascular diseases
5.1.1.2 Increasing Aging Population
5.1.1.3 Good Reimbursement Facilities
5.1.2 Opportunities
5.1.2.1 Increase in healthcare spending
5.1.2.2 Use of Electronic Health Records for Monitoring Outcomes of The Pacemake
5.1.2.3 Increase in the number of outpatient procedures
5.1.3 Restraints
5.1.3.1 Side Effects of Pacemakers
5.1.3.2 Alternative for Pacemakers
5.1.3.3 Lack of skilled healthcare professionals
5.1.3.4 Stringent Regulatory Approval Process
5.2 DRO - Impact Analysis
5.3 Key Stakeholders
6 Product: Market Size and Analysis
6.1 Overview
6.2 External Pacemakers
6.3 Internal Pacemaker
7 Technology: Market Size and Analysis
7.1 Overview
7.2 Single Chamber Pacemaker
7.3 Dual Chamber Pacemaker
7.4 Biventral Pacemaker
8 End-users: Market Size and Analysis
8.1 Overview
8.2 Hospitals and clinics
8.3 Ambulatory Surgical Center
8.3.1.1 US
8.4 Cardiac Centers
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.2.1 Overview
9.2.2 United States
9.2.3 Canada
9.3 Europe
9.3.1 Overview
9.3.2 UK 60
9.3.3 Germany
9.3.4 France
9.4 Asia Pacific
9.4.1 Overview
9.4.2 India
9.4.3 Japan
9.4.4 China
9.5 Rest of the World
9.5.1 Overview
9.5.2 Brazil
9.5.3 Africa
10 Competitive Landscape
11 Vendors Profile
11.1 Medtronic Plc
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.1 SWOT Analysis
11.1.2 Business Strategies
11.2 Abbott Laboratories
11.2.1 Overview
11.2.2 Business Unit
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategy
11.3 Boston Scientific Corp
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Biotronik Inc.
11.4.1 Overview
11.4.2 Business Focus
11.4.3 SWOT Analysis
11.4.4 Business Strategy
11.5 MicroPort Scientific Corporation
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 Vendors Profile
12.1 Shree Pacetronix Ltd.
12.1.1 Overview
12.2 OSYPKA AG
12.2.1 Overview
12.3 Medico S.p.A.
12.3.1 Overview
12.4 Oscor Inc.
12.4.1 Overview
12.5 Lepu Medical Technology Co. Ltd.
12.5.1 Overview
13 Annexure
Abbreviations